3.1 Sepsis & Septic Shock: Surviving Sepsis Campaign 2026 Resuscitation
Key Takeaways
Sepsis-3 defines sepsis as life-threatening organ dysfunction (acute SOFA rise of 2 or more points); septic shock adds a vasopressor need to keep MAP at or above 65 mmHg plus lactate above 2 mmol/L despite fluids.
SSC 2026 recommends NEWS, NEWS2, MEWS or SIRS over qSOFA as a single screening tool, and antimicrobials within 1 hour for possible shock or probable sepsis (within 3 hours for possible sepsis without shock).
SSC 2026 suggests at least 30 mL/kg of IV crystalloid in the first 3 hours for sepsis-induced hypoperfusion, balanced crystalloids over 0.9% saline, peripheral vasopressors rather than waiting for a central line, and an initial MAP target of 65 mmHg (60–65 mmHg at age 65 or older).
Norepinephrine is first-line; SSC 2026 suggests adding vasopressin as norepinephrine doses escalate (panel members typically start near 0.3 mcg/kg/min) and then epinephrine if MAP is still inadequate.
SSC 2026 suggests IV corticosteroids for septic shock; most panelists use hydrocortisone 200 mg/day, usually as intermittent doses, and do not routinely add fludrocortisone.
Sepsis & Septic Shock: Surviving Sepsis Guideline Resuscitation
Sepsis-3 Diagnostic Criteria and Pathophysiological Foundations
Under the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. In clinical practice, acute organ dysfunction is quantified by an acute change in total Sequential Organ Failure Assessment (SOFA) score of ≥2 points attributable to the infectious insult. The baseline SOFA score is assumed to be zero unless the patient is known to have pre-existing chronic organ dysfunction.
Note
While quick SOFA (qSOFA)—consisting of respiratory rate ≥22 breaths/min, altered mentation (Glasgow Coma Scale <15), and systolic blood pressure (SBP) ≤100 mmHg—was introduced as a bedside screening tool for patients at risk of deterioration, the 2026 Surviving Sepsis Campaign (SSC) guideline gives a strong recommendation to use NEWS, NEWS2, MEWS or SIRS rather than qSOFA as a single screening tool, because qSOFA is insensitive. It also states that sepsis is a clinical diagnosis that no single biomarker rules in or out.
Septic shock is recognized as a profound metabolic and circulatory subset of sepsis wherein cellular and vascular dysfunctions substantially increase hospital mortality beyond 40%. Clinically, septic shock is defined by the coexistence of:
- Persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) ≥65 mmHg, AND
- A serum lactate >2 mmol/L (>18 mg/dL) despite adequate intravenous volume resuscitation.
The pathophysiology involves pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) triggering systemic cytokine cascades (TNF-α, IL-1, IL-6), leading to endothelial nitric oxide synthase (eNOS) activation, loss of vascular tone, pathological glycocalyx shedding, diffuse microvascular leakage, relative and absolute hypovolemia, and impaired cellular oxygen extraction.
Surviving Sepsis Campaign 2026: The First Hours
The 2026 SSC adult guideline (129 statements, published March 2026) keeps the core "hour-1" logic: sepsis and septic shock are emergencies and treatment starts immediately. The table below combines the bundle elements with the 2026 timing language.
| Bundle Component | Action Window & Target | Clinical Rationale & Pearls |
|---|---|---|
| Measure Serum Lactate | Baseline immediately; repeat within 2–4 hours | Lactate serves as a surrogate marker of tissue hypoperfusion and anaerobic metabolism; lactate clearance (>20% reduction every 2 hours) correlates with resuscitation success. |
| Obtain Blood Cultures | Prior to initiating antimicrobials | Obtain 2 sets (aerobic and anaerobic) from separate venipuncture sites; do not delay antimicrobial administration by >45 minutes if culturing is technically difficult. |
| Broad-Spectrum Antimicrobials | Within 1 hour for possible, probable or definite septic shock and for probable or definite sepsis; within 3 hours for possible sepsis without shock if infection is still suspected after rapid evaluation | Avoid routine empiric antifungal or anaerobic coverage in low-risk patients; give prolonged (extended) infusions of beta-lactams after the loading dose (strong recommendation). Older data (Kumar 2006) linked each hour of delay in septic shock to about 7.6% lower survival. |
| Rapid IV Fluid Resuscitation | Initiate immediately; at least 30 mL/kg in the first 3 hours (suggestion) | Give for sepsis-induced hypoperfusion: hypotension (MAP <65 mmHg or SBP <90 mmHg) or lactate ≥4 mmol/L; SSC 2026 also asks clinicians to consider fluids for intermediate lactate (2 to <4 mmol/L). Reassess with dynamic measures and capillary refill time. |
| Vasopressor Initiation | During or immediately after fluid resuscitation | Titrate to maintain MAP ≥65 mmHg; do not withhold vasopressors until the full 30 mL/kg fluid bolus is finished if the patient has life-threatening hypotension. |
Important
Fluid dosing is based on actual body weight in normal-weight individuals. However, in patients with severe obesity (body mass index ≥30 kg/m²), strictly using actual body weight can cause severe fluid overload and pulmonary edema. Emergency clinical consensus often utilizes ideal body weight (IBW) or an adjusted body weight formula (IBW + 0.4 × [Actual - IBW]) to prevent iatrogenic volume toxicity. Peripheral vasopressor administration via an intact 18-gauge or 20-gauge catheter placed in the forearm or antecubital fossa is safe and guideline-endorsed while central venous access is being established.
Crystalloid Selection: Balanced Crystalloids vs. 0.9% Normal Saline
Fluid selection in septic shock significantly impacts renal outcomes and acid-base equilibrium. For decades, 0.9% Normal Saline (NS) was the standard resuscitative crystalloid. However, large landmark randomized trials have shifted practice firmly toward balanced crystalloids.
| Crystalloid Solution | Na⁺ (mEq/L) | Cl⁻ (mEq/L) | K⁺ (mEq/L) | Buffer Component | Osmolarity (mOsm/L) |
|---|---|---|---|---|---|
| 0.9% Normal Saline | 154 | 154 | 0 | None (Strong Ion Diff = 0) | 308 |
| Lactated Ringer's (LR) | 130 | 109 | 4 | Sodium Lactate (28 mEq/L) | 273 |
| Plasma-Lyte A | 140 | 98 | 5 | Acetate (27), Gluconate (23) | 294 |
Evidence from SMART and SALT-ED Trials
The SMART trial (ICU population, n=15,802) and SALT-ED trial (non-ICU emergency department population, n=13,347) found that balanced crystalloids (LR or Plasma-Lyte) produced a small but statistically significant reduction in Major Adverse Kidney Events within 30 days (MAKE30), a composite of death, new renal replacement therapy (RRT) or persistent renal dysfunction, compared with 0.9% saline. A secondary analysis of SMART patients with sepsis suggested lower 30-day mortality with balanced fluids. The later BaSICS and PLUS trials found no significant mortality difference. SSC 2026 therefore suggests (conditional recommendation) balanced crystalloids over 0.9% saline for initial resuscitation, with a remark favoring 0.9% saline when sepsis accompanies traumatic brain injury. It also suggests crystalloids alone over adding albumin, and recommends against starches.
Pathophysiological Mechanism of Saline Harm
0.9% Normal Saline delivers a supraphysiologic chloride load (154 mEq/L vs. normal serum chloride 96–106 mEq/L). Hyperchloremia leads to excess chloride delivery to the macula densa in the juxtaglomerular apparatus, triggering tubuloglomerular feedback that constricts the afferent renal arteriole. This causes a dramatic reduction in renal cortical perfusion and glomerular filtration rate (GFR). Furthermore, unbuffered 0.9% saline drives bicarbonate into cells and induces a hyperchloremic non-anion gap metabolic acidosis. The lactate in Lactated Ringer's is rapidly metabolized by the liver into bicarbonate and does not exacerbate lactic acidosis.
Vasopressor Titration Hierarchy & Receptor Profiles
When fluid resuscitation fails to restore a MAP ≥65 mmHg, vasoactive infusions must be titrated systematically.
| Agent | Receptor Activity | Hemodynamic Effect | Dosing Range | Clinical Role in Sepsis |
|---|---|---|---|---|
| Norepinephrine | α₁ +++; β₁ ++; β₂ + | ↑ SVR, ↑ MAP, mild ↑ CO, minimal chronotropy | 0.01–3 mcg/kg/min (or 2–30 mcg/min) | First-line vasopressor across all septic shock guidelines. |
| Vasopressin | V₁ +++; V₂ ++ | ↑ SVR, ↑ MAP, neutral CO, catecholamine-sparing | 0.03 units/min (usually fixed; some protocols allow 0.04) | Second-line adjunct on escalating norepinephrine; SSC 2026 panel members typically start it near 0.3 mcg/kg/min of norepinephrine. |
| Epinephrine | α₁ +++; β₁ +++; β₂ ++ | ↑ SVR, ↑ MAP, ↑↑ CO, ↑↑ HR, ↑ inotropy | 0.01–0.5 mcg/kg/min | Third-line agent added to norepinephrine or second-line when inotropy needed. |
| Phenylephrine | α₁ +++ | ↑ SVR, ↑ MAP, neutral/↓ CO, reflex bradycardia | 0.5–5 mcg/kg/min (or 20–200 mcg/min) | Reserved for severe tachydysrhythmias or salvage therapy. |
| Dopamine | DA + (low); β₁ ++ (mid); α₁ +++ (high) | ↑ SVR, ↑ CO, profound ↑ HR & arrhythmogenicity | 2–20 mcg/kg/min | Alternative only in highly selected patients with bradycardia and low arrhythmic risk. |
First-Line: Norepinephrine
Norepinephrine provides potent α₁-mediated peripheral vasoconstriction with modest β₁-adrenergic inotropic stimulation. It increases MAP and systemic vascular resistance (SVR) while preserving stroke volume with less tachyarrhythmia than dopamine or epinephrine.
Second-Line: Vasopressin
In septic shock, neurohypophyseal stores of endogenous arginine vasopressin are rapidly exhausted, leading to a state of relative vasopressin deficiency. Exogenous vasopressin stimulates vascular V₁ receptors coupled to G_q proteins, raising intracellular calcium via the IP3/DAG cascade and closing ATP-sensitive potassium channels (K_ATP). This restores vascular tone even in acidic, catecholamine-resistant vascular beds.
- Vasopressin is initiated at a fixed dose of 0.03 units/min.
- It is never titrated like catecholamines; titration above 0.03–0.04 units/min causes severe splanchnic, mesenteric, and digital ischemia without hemodynamic benefit.
Third-Line: Epinephrine
Epinephrine is recommended when norepinephrine and vasopressin fail to achieve target MAP, or when myocardial depression coexists with vasodilatory shock. Clinicians must recognize that epinephrine stimulation of skeletal muscle β₂-receptors accelerates aerobic glycolysis, generating pyruvate faster than it can enter the Krebs cycle. This causes a transient, self-limiting rise in serum lactate that reflects drug pharmacology rather than worsening tissue hypoperfusion.
Adjunctive Corticosteroid Pharmacotherapy
Prolonged septic shock is frequently complicated by Critical Illness-Related Corticosteroid Insufficiency (CIRCI), characterized by hypothalamic-pituitary-adrenal axis dysfunction and tissue corticosteroid receptor resistance.
Guideline Indication and Dosing Regimen
The 2026 SSC guideline suggests IV corticosteroids for adults with septic shock (conditional recommendation, low-certainty evidence). A meta-analysis of 45 trials showed more shock reversal at 7 days and a possible small mortality reduction, at the cost of more hyperglycemia and hypernatremia. There is no benefit in sepsis without shock.
- Timing: SSC 2026 sets no fixed vasopressor threshold. The 2021 guideline's practice note (norepinephrine or epinephrine at 0.25 mcg/kg/min or more for at least 4 hours) is still a common local trigger, but panelists start steroids anywhere from below 0.2 to above 0.3 mcg/kg/min.
- Drug & Regimen: IV hydrocortisone 200 mg/day, most often as 50 mg IV every 6 hours (about 86% of panelists) or as a continuous infusion of 200 mg over 24 hours. Doses above about 260 mg/day add no benefit.
- Fludrocortisone: most panelists do not add it routinely.
- Stopping: many clinicians stop without a taper once shock resolves; others taper.
Tip
Routine ACTH stimulation testing is not recommended to guide corticosteroid initiation in septic shock. Diagnostic testing delays therapy and fails to identify patients who will clinically benefit.
Landmark Trial Evidence: ADRENAL vs. APROCCHSS
Two pivotal randomized clinical trials guide modern corticosteroid use:
- ADRENAL Trial (n=3,800): Evaluated continuous infusion hydrocortisone (200 mg/day) vs. placebo. Hydrocortisone did not reduce 90-day all-cause mortality, but it significantly accelerated time to shock resolution (median 3 vs. 4 days, p < 0.001), reduced ICU length of stay, and decreased blood transfusion requirements.
- APROCCHSS Trial (n=1,241): Evaluated hydrocortisone (50 mg IV q6h) PLUS oral fludrocortisone (50 mcg once daily via NG tube) in patients with severe septic shock on high-dose vasopressors. This trial demonstrated a statistically significant reduction in 90-day all-cause mortality (43.0% vs. 49.1%, p=0.03).
- Clinical Synthesis: Hydrocortisone reliably shortens vasopressor duration and speeds shock reversal. Fludrocortisone remains optional because hydrocortisone at 200 mg/day already has mineralocorticoid activity.
Worked Resuscitation Case & Clinical Pearls
Case Presentation: A 65-year-old female (actual weight 70 kg, height 5'4", ideal body weight 53 kg) presents with septic shock secondary to pyelonephritis. Blood pressure is 74/42 mmHg (MAP 53 mmHg), heart rate 124 bpm, respiratory rate 26 breaths/min, and initial serum lactate is 4.8 mmol/L.
- Volume Resuscitation: 30 mL/kg × 70 kg = 2,100 mL of Lactated Ringer's initiated immediately on a pressure bag.
- Antimicrobial Timing: Blood cultures × 2 drawn immediately; Cefepime 2 g IV + Vancomycin 1,500 mg IV initiated within 45 minutes of arrival.
- Vasoactive Support: Norepinephrine initiated via a dedicated 18G peripheral line in the forearm at 0.05 mcg/kg/min (3.5 mcg/min) and rapidly titrated upward to achieve MAP ≥65 mmHg while fluid is infusing.
- Second-Line Escalation: At 90 minutes, 2 L of LR has infused, but norepinephrine has escalated to 0.28 mcg/kg/min to maintain MAP 65 mmHg. Vasopressin is initiated at a fixed rate of 0.03 units/min.
- Corticosteroid Evaluation: Because vasopressor requirements exceed 0.25 mcg/kg/min beyond 4 hours, Hydrocortisone 50 mg IV every 6 hours is added to speed shock resolution.
Warning
Do not delay vasopressor initiation waiting for central line placement or completion of crystalloid boluses. Prolonged hypotension with MAP <65 mmHg leads to acute tubular necrosis and myocardial injury. Peripheral norepinephrine in dilute concentration is safe for several hours when infused through a verified vein proximal to the wrist.
A 62-year-old male weighing 80 kg presents to the emergency department with altered mental status, fever (38.9°C), heart rate 122 bpm, blood pressure 78/44 mmHg (MAP 55 mmHg), and an initial serum lactate of 5.2 mmol/L. The patient has a history of stage 3 chronic kidney disease. In accordance with the Surviving Sepsis Campaign guidelines and evidence from the SMART trial, which initial fluid resuscitation strategy is most appropriate?
Administer 30 mL/kg of 5% Albumin as the sole primary resuscitation fluid within 1 hour followed by high-dose dopamine infusion
Withhold crystalloid boluses due to baseline renal impairment and immediately place a central venous line for phenylephrine monotherapy
Administer 2,400 mL of Lactated Ringer's IV within 3 hours, initiate blood cultures, and administer broad-spectrum antimicrobials within 1 hour
Administer 1,000 mL of 0.9% Normal Saline over 6 hours to prevent worsening chronic kidney disease and await repeat lactate results
A 58-year-old female with septic shock secondary to pneumonia has received 30 mL/kg of balanced crystalloids. Her blood pressure remains 80/46 mmHg (MAP 57 mmHg) despite norepinephrine titrated to 0.3 mcg/kg/min. Serum lactate is 3.8 mmol/L. According to guideline-directed resuscitation, which intervention represents the next recommended hemodynamic step?
Administer an intravenous bolus of 500 mg methylprednisolone followed by an uncalibrated dopamine infusion
Add vasopressin at a fixed continuous infusion rate of 0.03 units/min
Discontinue norepinephrine and transition immediately to phenylephrine infusion titrated to 200 mcg/min
Increase norepinephrine up to 5 mcg/kg/min before considering any secondary vasoactive agent
A 71-year-old male with septic shock remains hypotensive requiring norepinephrine at 0.35 mcg/kg/min and vasopressin at 0.03 units/min 5 hours after ED arrival despite adequate fluid resuscitation. Which statement accurately reflects the evidence and clinical recommendations regarding adjunctive corticosteroid therapy in this patient?
Corticosteroids are contraindicated in septic shock due to the absence of shock reversal in randomized trials
Intravenous hydrocortisone 200 mg/day should be initiated to accelerate shock resolution and reduce vasopressor duration
Dexamethasone 10 mg IV every 6 hours is preferred over hydrocortisone due to its lack of mineralocorticoid activity
Corticosteroid therapy should be withheld until an ACTH stimulation test confirms adrenal insufficiency
Sections you finish are checked off in the contents.